(Total Views: 165)
Posted On: 12/02/2019 4:00:43 PM
Post# of 124816
$RFL News Article - Rafael Pharmaceuticals Announces Expansion of Phase 2 Trial of CPI-613 (devimistat) for Patients with Relapsed or Refractory Burkitt's Lymphoma/Leukemia to Massachusetts General Hospital in Boston https://marketwirenews.com/news-releases/rafa...89706.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
